Free Trial

10x Genomics (TXG) SEC Filings & 10K Form

10x Genomics logo
$7.47 -0.50 (-6.27%)
Closing price 04:00 PM Eastern
Extended Trading
$7.66 +0.20 (+2.61%)
As of 07:17 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent 10x Genomics SEC Filings

DateFilerForm TypeView
03/19/2025
4:34 PM
10x Genomics (Issuer)
Taich Adam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
4:35 PM
10x Genomics (Issuer)
Hindson Benjamin J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
4:35 PM
10x Genomics (Issuer)
Saxonov Serge (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
5:50 PM
10x Genomics (Issuer)
Saxonov Serge (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2025
4:03 PM
10x Genomics (Subject)
Saxonov Serge (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2025
4:42 PM
10x Genomics (Issuer)
Saxonov Serge (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
4:43 PM
10x Genomics (Issuer)
Hindson Benjamin J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
4:22 PM
10x Genomics (Issuer)
MATEO ALAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2025
7:01 PM
10x Genomics (Subject)
Saxonov Serge (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/24/2025
6:35 PM
10x Genomics (Subject)
Hindson Benjamin J. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
8:23 AM
10x Genomics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/13/2025
7:49 AM
10x Genomics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/23/2024
7:29 PM
10x Genomics (Issuer)
Saxonov Serge (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
3:53 PM
10x Genomics (Issuer)
Saxonov Serge (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
3:52 PM
10x Genomics (Issuer)
Hindson Benjamin J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
3:56 PM
10x Genomics (Subject)
Hindson Benjamin J. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/22/2024
3:38 PM
10x Genomics (Subject)
Saxonov Serge (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/18/2024
3:43 PM
10x Genomics (Issuer)
Saxonov Serge (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2024
1:46 PM
10x Genomics (Subject)
Nikko Asset Management Americas, Inc. (Filed by)
Form SC 13G
11/05/2024
5:07 AM
10x Genomics (Subject)
Sumitomo Mitsui Trust Group, Inc. (Filed by)
Form SC 13G
10/09/2024
3:07 PM
10x Genomics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2024
1:14 PM
10x Genomics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
09/04/2024
4:34 PM
10x Genomics (Issuer)
Teichmann Sarah A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/26/2024
4:03 PM
10x Genomics (Issuer)
10x Genomics (Issuer)
McAnear Justin J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/26/2024
4:04 PM
10x Genomics (Issuer)
10x Genomics (Issuer)
Hindson Benjamin J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/26/2024
4:05 PM
10x Genomics (Issuer)
10x Genomics (Issuer)
Saxonov Serge (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
7:39 PM
10x Genomics (Subject)
Hindson Benjamin J. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/22/2024
7:42 PM
10x Genomics (Subject)
McAnear Justin J. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/22/2024
7:45 PM
10x Genomics (Subject)
Saxonov Serge (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/12/2024
10:16 AM
10x Genomics (Subject)
ARK Investment Management LLC (Filed by)
Form SC 13G
07/19/2024
3:42 PM
10x Genomics (Issuer)
Teichmann Sarah A. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/26/2024
3:48 PM
10x Genomics (Issuer)
MATEO ALAN (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/13/2024
3:08 PM
10x Genomics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2024
8:55 AM
10x Genomics (Subject)
BAILLIE GIFFORD & CO (Filed by)
Form SC 13G/A
05/23/2024
6:52 PM
10x Genomics (Issuer)
Hindson Benjamin J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
6:53 PM
10x Genomics (Issuer)
Saxonov Serge (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
6:54 PM
10x Genomics (Issuer)
McAnear Justin J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
3:23 PM
10x Genomics (Subject)
Saxonov Serge (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/22/2024
3:27 PM
10x Genomics (Subject)
Hindson Benjamin J. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/22/2024
3:17 PM
10x Genomics (Subject)
McAnear Justin J. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/12/2024
3:23 PM
10x Genomics (Filer)
Form PRE 14A
Now I look stupid. Real stupid... (Ad)

I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:TXG) was last updated on 4/4/2025 by MarketBeat.com Staff
From Our Partners